Swapan Chowdhury, PhD

VP DMPK

Swapan Chowdhury was named Vice President of DMPK in March 2023 with responsibilities that include scientific and strategic leadership on all aspects of drug metabolism, pharmacokinetics, bioanalytical, and immunogenicity for BP programs. He is responsible for providing oversight to contractors, consultants, and vendors supporting DMPK and clinical pharmacology activities.  Swapan joined Boston Pharmaceuticals in September 2021 as the Executive director of DMPK. 

Prior to joining BP, Swapan was a Senior Director and head of the ADME group within global DMPK at Takeda Pharmaceutical Company and served for 10 years with increasing leadership roles.  Prior to Takeda, Swapan served 16 years at Schering-Plough/Merck in various leadership roles within Drug Metabolism Department. Overall, he has more than 25 years of diverse experience in Research and Development.  Swapan holds a Ph.D. degree in Chemistry from the University of Alberta, Edmonton, Canada.